HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoyuki Nakasa Selected Research

septide

10/2022Therapeutic effect of targeting Substance P on the progression of osteoarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoyuki Nakasa Research Topics

Disease

12Osteoarthritis
10/2022 - 05/2008
5Rheumatoid Arthritis
01/2021 - 05/2008
4Wounds and Injuries (Trauma)
07/2019 - 04/2009
4Arthritis (Polyarthritis)
06/2011 - 09/2009
3Sclerosis
10/2022 - 01/2016
3Congenital Abnormalities (Deformity)
06/2022 - 01/2021
2Pain (Aches)
10/2022 - 01/2021
2Osteophyte
05/2022 - 01/2020
2Knee Osteoarthritis
01/2021 - 01/2020
2Lacerations
10/2010 - 04/2009
1Cysts
05/2022
1Rupture
01/2022
1Osteolysis
01/2021
1Hallux Varus
01/2021
1Patellar Dislocation
06/2020
1Bone Diseases (Bone Disease)
12/2015
1Osteoporosis
12/2015
1Stress Fractures (Stress Fracture)
03/2015
1Clubfoot (Talipes Equinovarus)
01/2015
1Hypoxia (Hypoxemia)
11/2012
1Osteonecrosis (Kienbock's Disease)
08/2012
1Fibrosis (Cirrhosis)
10/2010
1Hyperplasia
09/2010
1Joint Diseases (Joint Disease)
06/2010

Drug/Important Bio-Agent (IBA)

7MicroRNAs (MicroRNA)IBA
12/2015 - 09/2010
2Therapeutic UsesIBA
10/2022 - 01/2016
2atelocollagenIBA
01/2021 - 10/2010
1Substance PIBA
10/2022
1septideIBA
10/2022
1Conditioned Culture MediaIBA
01/2022
1LectinsIBA
01/2022
1GelsIBA
01/2021
1poly(lactide) (polylactic acid)IBA
01/2021
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
01/2021
1Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
09/2020
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
09/2020
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2016
11- (N(2)- (3,4- dibromo- N- ((4- (3,4- dihydro- 2(1H)- oxoquinazolin- 3- yl)- 1- piperidinyl)carbonyl)tyrosyl)lysyl)- 4- (4- pyridinyl)piperazineIBA
01/2016
1Heme Oxygenase-1IBA
10/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012
1Small Untranslated RNAIBA
11/2012
1Double-Stranded RNA (RNA, Double Stranded)IBA
06/2011
1Small Interfering RNA (siRNA)IBA
10/2010
1Interleukin-17 (Interleukin 17)IBA
09/2010
1InterleukinsIBA
09/2010
1AntigensIBA
06/2010
1Peptide Hydrolases (Proteases)FDA Link
06/2010
1AutoantibodiesIBA
09/2009
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2009
1Phosphates (Orthophosphate)IBA
04/2009
1Interleukin-1beta (Interleukin 1 beta)IBA
05/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2008

Therapy/Procedure

4Arthrodesis
06/2022 - 07/2019
3Bone Plates (Bone Plate)
05/2022 - 12/2014
2Arthroscopes
02/2018 - 03/2015
1Osteotomy
06/2022
1Drug Therapy (Chemotherapy)
01/2021
1Sutures (Suture)
01/2021
1Tendon Transfer
01/2021
1Anterior Cruciate Ligament Reconstruction
06/2020
1Minimally Invasive Surgical Procedures
07/2019
1Traction
01/2018
1External Fixators
03/2015
1Arthroplasty
03/2015
1Splints (Splint)
01/2015
1Conservative Treatment
01/2015
1Intravenous Injections
06/2011
1Intra-Articular Injections
09/2009
1Therapeutics
04/2009